×

Looking to JAZZ Up Your Portfolio?

6:25 PM ET Fri, 7 June 2013

Jazz Pharmaceuticals' stock has roared, says Mad Money host Jim Cramer. The company gets 69 percent of its sales from its narcolepsy drug Xyrem which has a wall of patents protecting the drug from competition.